MATTHEW HARRISON: Open Payments
NPI 1811489230 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$874 in 57 payments from 16 companies in 2025. Trend: 2023 $1,321 · 2024 $1,313 · 2025 $874
Food & beverage: $874
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $234 |
| PFIZER INC. | 7 | $117 |
| Novo Nordisk Inc | 7 | $115 |
| Exact Sciences Corporation | 6 | $93 |
| Lilly USA, LLC | 4 | $72 |
| Vanda Pharmaceuticals Inc. | 2 | $50 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| Verity Pharmaceuticals Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
Products named: VRAYLAR, Ozempic, Cologuard Collection Kit, ELIQUIS, PREVNAR 20, MOUNJARO, Rybelsus, HETLIOZ.
Industry payments across KY — which companies pay providers there.
